Tomeki

Oversight of the drug development program of the National Cancer Institute, 1982

Oversight of the drug development program of the National Cancer Institute, 1982

hearing before the Subcommittee on Investigations and General Oversight of the Committee on Labor and Human Resources, United States Senate, Ninety-seventh Congress, second session on examination of effective alternatives toward correcting deficiencies in the use of experimental drugs on cancer patients, March 5, 1982.

By United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Investigations and General Oversight.

0 (0 Ratings)
0 Want to read0 Currently reading0 Have read

Publish Date

1982

Publisher

U.S. G.P.O.

Language

eng

Pages

300